Aortic occlusion
(UMLS:C0596118)
- UMLS ID:
- C0596118
- MeSH ID:
- N/A
Synonym(s)
1.
Aortic occlusion
2.
aorta obstruction
3.
aorta; obstruction
4.
aortic obstruction
5.
aortic occlusion
6.
obstruction aorta
7.
obstruction; aortic
Associated Drug(s)
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | rofecoxib | FAERS: 19 | OFFSIDES US FAERS | |
| 2 | Paroxetine | FAERS: 8 | US FAERS | |
| 3 | Octreotide | FAERS: 7 | US FAERS | |
| 4 | Valsartan | FAERS: 6 | US FAERS | |
| 5 | Alendronate | FAERS: 4 | US FAERS | |
| 6 | Varenicline | FAERS: 3 | US FAERS | |
| 7 | 4-methyl-N-(3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-pyridin-3-ylpyrimidin-2-yl)amino)benzamide | FAERS: 2 | US FAERS | |
| 8 | Atorvastatin | FAERS: 2 | US FAERS | |
| 9 | Dimethyl Fumarate | FAERS: 2 | US FAERS | |
| 10 | Pregabalin | FAERS: 2 | US FAERS | |
| 11 | Rosiglitazone | FAERS: 2 | US FAERS | |
| 12 | Teriparatide | FAERS: 2 | US FAERS | |
| 13 | Zoledronic Acid | FAERS: 2 | US FAERS | |
| 14 | 5-(4-ethylpiperazin-1-ylmethyl)pyridin-2-yl)-(5-fluoro-4-(7-fluoro-3-isopropyl-2-methyl-3H-benzimidazol-5-yl)pyrimidin-2-yl)amine | FAERS: 1 | US FAERS | |
| 15 | Albuterol | FAERS: 1 | US FAERS | |
| 16 | BMS201038 | FAERS: 1 | US FAERS | |
| 17 | Capecitabine | FAERS: 1 | US FAERS | |
| 18 | Clopidogrel | FAERS: 1 | US FAERS | |
| 19 | Clozapine | FAERS: 1 | US FAERS | |
| 20 | Dabigatran | FAERS: 1 | US FAERS | |
| 21 | Esomeprazole | FAERS: 1 | US FAERS | |
| 22 | Exenatide | FAERS: 1 | US FAERS | |
| 23 | Glatiramer Acetate | FAERS: 1 | US FAERS | |
| 24 | Latanoprost | FAERS: 1 | US FAERS | |
| 25 | Lenalidomide | FAERS: 1 | OFFSIDES US FAERS | |
| 26 | Linagliptin | FAERS: 1 | US FAERS | |
| 27 | MDV 3100 | FAERS: 1 | US FAERS | |
| 28 | Omeprazole | FAERS: 1 | US FAERS | |
| 29 | Prasugrel Hydrochloride | FAERS: 1 | US FAERS | |
| 30 | Ranolazine | FAERS: 1 | US FAERS | |
| 31 | Rosuvastatin Calcium | FAERS: 1 | US FAERS | |
| 32 | Sunitinib | FAERS: 1 | US FAERS | |
| 33 | Ticagrelor | FAERS: 1 | US FAERS | |
| 34 | Tiotropium Bromide | FAERS: 1 | US FAERS | |
| 35 | Warfarin | FAERS: 1 | US FAERS | |
| 36 | apixaban | FAERS: 1 | US FAERS | |
| 37 | eltrombopag | FAERS: 1 | US FAERS | |
| 38 | palbociclib | FAERS: 1 | US FAERS | |
| 39 | ponatinib | FAERS: 1 | US FAERS | |
| 40 | valdecoxib | FAERS: 1 | US FAERS | |
| 41 | Acarbose | OFFSIDES | ||
| 42 | Hydromorphone | OFFSIDES | ||
| 43 | Methocarbamol | OFFSIDES | ||
| 44 | Octreotide | Canada Vigilance: 1 | Canada Vigilance | |
| 45 | Ribavirin | OFFSIDES | ||
| 46 | azelastine | OFFSIDES | ||
| 47 | benzonatate | OFFSIDES | ||
| 48 | testosterone enanthate | OFFSIDES |
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120241
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.